Obviously companies going ahead with ph III trials, RVX, PPHM or any others....obvioulsy there's a level of comfort from earlier trial results, if there wasn't success in phas I/II/IIb then they wouldn't be going forward with ph III.
But that doesn't mean there still isn't a big risk of failure.